Overcoming Therapy Resistance and Relapse in TNBC: Emerging Technologies to Target Breast Cancer-Associated Fibroblasts

Breast cancer is the most diagnosed cancer and is the leading cause of cancer mortality in women. Triple-negative breast cancer (TNBC) is an aggressive form of breast cancer. Often, TNBC is not effectively treated due to the lack of specificity of conventional therapies and results in relapse and me...

Descripción completa

Detalles Bibliográficos
Autores principales: Mollah, Farhana, Varamini, Pegah
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8698629/
https://www.ncbi.nlm.nih.gov/pubmed/34944738
http://dx.doi.org/10.3390/biomedicines9121921

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8698629/
https://www.ncbi.nlm.nih.gov/pubmed/34944738
http://dx.doi.org/10.3390/biomedicines9121921

Ejemplares similares